A novel safe strategy to generate integration-free human induced pluripotent stem cells using Newcastle Disease Virus as a gene delivery vector
Cost in Lakh: 59.50
Duration: 3 years (02/2023-02/2026)
Agency: DBT
Investigating the role of UTF1 in the generation of human induced pluripotent stem cells
Cost in Lakh: 52.34
Duration: 3 years (12/2021-12/2024)
Agency: DST-SERB
Direct reprogramming of human fibroblasts to functional cardiomyocytes for cell therapy
Cost in Lakh: 40.12
Duration: 3 years (06/2016-06/2019)
Agency: DST-SERB
Generation of transgene-free human induced pluripotent stem cells using non-genetic approaches for cell therapeutic applications
Cost in Lakh: 85.28 (51.31 for IITG & 33.97 for NCCS)
Duration: 3 years (11/2016-11/2019)
Agency: DBT
Establishment of a cell-permeant recombinant protein toolbox for the conversion of adult human somatic cells to insulin producing β-cells
Cost in Lakh: 15.99 (10.55 for NIPER-Guwahati and 2.31 for IITG)
Duration: 2.5 years (04/2019-09/2021)
Agency: NECBH (DBT)
Dr. Ranadeep Gogoi, Department of Biotechnology, NIPER Guwahati; as a Principal Investigator
NECBH
Funding Agency: Department of Biotechnology, Government of India
Period: 2019-2021